Notably, the SPHK1 inhibitor PF-543 partially attenuated the pro-tumorigenic effects of rhENO1 on GBM cell proliferation, migration, and invasion (Supplementary Fig. 7A–D). The gene discussed is SPHK1; the disease is glioblastoma.